AK Medical Holdings Limited

HardwareBeijing, ChinaFounded 2003· One of 1804 Hardware companies tracked by AMPulse

Chinese orthopedic implant manufacturer that commercialized 3D printing technology for joint replacement, spine, and trauma implants; listed on Hong Kong Stock Exchange (1789.HK)

CEO / Founder: Li Zhijiang (李志疆)
Team Size: 1001-5000
Stage: Public
Total Funding: Publicly Traded
Latest Round: IPO
Key Investors: Public shareholders (HKEX); OrbiMed (pre-IPO investor)

Technology & Products

Key Products

3D-printed hip replacement implants (acetabular cups, femoral stems); 3D-printed knee prostheses (including first metal 3D-printed tibial tray in China); 3D-printed spinal interbody cages and artificial vertebral bodies; 3D-printed customized implants for complex cases (tumor, trauma); ICOS (Innovative Custom Orthopedic Solution) personalized platform; VTS (Visual Treatment Solution) intelligent surgical planning; iBot surgical robot; Supravit HA-coated implants via JRI

Technological Advantage

Four proprietary technology platforms: (1) 3D ACT metal additive manufacturing for bone-like porous structures; (2) Supravit vacuum plasma spraying (VPS) HA coating via JRI; (3) Smart orthopedic technology (VTS/IBot surgical robots); (4) ICOS personalized orthopedic solutions. Asia's largest 3D printing base for orthopedics with 8 GE Additive Arcam EBM systems. 600+ patents globally.

Differentiation

Value Proposition

World's first company to commercialize additive manufacturing (3D printing) for orthopedic implants, offering a comprehensive portfolio of hip, knee, spine, and trauma implants with 3D-printed bone-like trabecular structures that promote osseointegration

How They Differentiate

First-mover advantage in 3D-printed orthopedic implants with the most extensive clinical track record; Asia's largest dedicated 3D printing facility for orthopedics; only Chinese orthopedic company with full 3D printing commercialization across hip, knee, spine, and trauma; vertically integrated with UK R&D and manufacturing (JRI) for global reach

Market & Competition

Target Customers

Hospitals, orthopedic surgeons, and healthcare institutions globally; patients requiring joint replacement, spine surgery, and trauma reconstruction

Industry Verticals

Orthopedic surgery (joint replacement, spine, trauma, tumor reconstruction)

Competitors

Chunli Medical (春立医疗); Weigao Orthopedics (威高骨科); Dabo Medical (大博医疗)

Growth & Milestones

Growth Metrics

FY2025 revenue: RMB 1.482B (~$205M), +10.1% YoY; FY2024 revenue: RMB 1.346B; Net profit FY2025: RMB 339M; 1.2M+ implants placed globally; one implant every 2 minutes

Major Milestones

2003: Founded; 2009: Began 3D printing R&D for orthopedics; 2015: First NMPA-approved 3D-printed hip implant system in China; 2017: IPO on HKEX (1789.HK); 2018: Acquired JRI Orthopaedics (UK); 2020: Acquired Beijing Libeier (formerly Medtronic subsidiary); 2023: Launched TCBridge 3D-printed customized long bone defect repair system; 2024: 3D printing & smart manufacturing base groundbreaking in Changping, Beijing

Notable Customers

7,500+ hospitals across 40+ countries including China, UK, Japan, South Korea, Spain, South Africa

https://www.ak-medical.net

Why this company matters

AK Medical is a Chinese orthopedic implant manufacturer that pioneered the use of metal additive manufacturing for joint replacement, spine, and trauma implants. Listed on the Hong Kong Stock Exchange (1789.HK), the company holds a first-mover advantage in 3D-printed orthopedics and operates Asia's largest dedicated 3D printing facility for this segment, equipped with eight GE Additive Arcam EBM systems.

The company's core technology platform, 3D ACT (Accurate Constructive Technology), produces porous bone-like trabecular structures designed to promote osseointegration. AK Medical's product line includes 3D-printed hip acetabular cups and femoral stems, knee prostheses (including China's first metal 3D-printed tibial tray), spinal interbody cages, artificial vertebral bodies, and customized implants for complex tumor and trauma cases via the ICOS personalized platform. Complementary technologies include the Supravit HA coating via UK subsidiary JRI, the VTS intelligent surgical planning system, and the iBot surgical robot.

AK Medical serves over 7,500 hospitals across 40 countries, including China, the UK, Japan, South Korea, Spain, and South Africa. The company holds the #1 position by sales volume in China's orthopedic joint implant market and ranks among the top 10 globally in hip replacement. FY2025 revenue reached RMB 1.482 billion (~$205 million), with net profit of RMB 339 million. More than 1.2 million implants have been placed globally, at a rate of one implant every two minutes.

Key competitive risks include the potential for other large orthopedic players to scale their own 3D printing capabilities, as well as pricing pressure in China's volume-driven hospital procurement environment. AK Medical's vertical integration—including UK R&D and manufacturing via JRI and a joint laboratory with Beijing Jishuitan Hospital—provides some insulation, but the company must continue to expand its global regulatory approvals and clinical evidence to defend its lead.